NT-proBNP and New Biomarkers in Patients With Dyspnea and/or Peripheral Edema (MANPRO)
Mannheim NT-proBNP Study (MANPRO) Evaluating NT-proBNP and New Biomarkers in Patients Suffering From Dyspnea and/or Peripheral Edema for the Differential Diagnosis of Congestive Heart Failure
Sponsor: Universitätsmedizin Mannheim
This observational or N/A phase trial investigates Dyspnea and Peripheral Edema and is currently completed. Universitätsmedizin Mannheim leads this study, which shows 12 recorded versions since 2005 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Dec 2021 [monthly]
Completed
-
Nov 2020 — Jan 2021 [monthly]
Completed
▶ Show 7 earlier versions
-
Sep 2020 — Nov 2020 [monthly]
Completed
Status: Unknown Status → Completed
-
Dec 2018 — Sep 2020 [monthly]
Unknown Status
Status: Active Not Recruiting → Unknown Status
-
Jun 2018 — Dec 2018 [monthly]
Active Not Recruiting
-
May 2018 — Jun 2018 [monthly]
Active Not Recruiting
-
Apr 2018 — May 2018 [monthly]
Active Not Recruiting
Phase: PHASE4 → None
-
Aug 2017 — Apr 2018 [monthly]
Active Not Recruiting PHASE4
-
Jan 2017 — Aug 2017 [monthly]
Active Not Recruiting PHASE4
First recorded
Jun 2005
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Universitätsmedizin Mannheim
For direct contact, visit the study record on ClinicalTrials.gov .